Angiotensin Receptor Blocking Blood Pressure May Fight CoVid19 episode artwork

EPISODE · Mar 24, 2020 · 0 MIN

Angiotensin Receptor Blocking Blood Pressure May Fight CoVid19

from Dr. Howard Smith OnCall · host Howard G. Smith MD, AM

  Vidcast:  https://youtu.be/AMGmbjdWo-o   The CoVid19 virus uses the angiotensin converting enzyme 2 or ACE2 as a binding site to human cells in the lungs, heart, and kidneys.  The angiotensin receptor blockers (ARBs) used to lower blood pressure increase ACE2 levels and may be able to diminish the damage the virus creates in vital organs.   Clinicians from China and India observe that the ARB drugs losartan and telmisartan bind strongest to the angiotensin receptors and would be most effective against CoVid19.  Since these drugs are already FDA-approved, drug trials using them for treating CoVid19 may be launched.   If you are on an ARB, stay on it as such studies unfold but don’t switch to it yet!   https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21656   https://www.bmj.com/content/368/bmj.m406/rr-2   #covid19 #coronavirus #angiotensin #arb

Episode metadata supplied by the publisher feed · Published Mar 24, 2020

Embed this episode

NOW PLAYING

Angiotensin Receptor Blocking Blood Pressure May Fight CoVid19

0:00 0:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dr. Howard Smith OnCall?

This episode is 0 minutes long.

When was this Dr. Howard Smith OnCall episode published?

This episode was published on March 24, 2020.

Can I download this Dr. Howard Smith OnCall episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!